Citation: Song Chao, Gao Dan, Yuan Tianying, Chen Yongli, Liu Liping, Chen Xiaowu, Jiang Yuyang. Microfluidic three-dimensional biomimetic tumor model for studying breast cancer cell migration and invasion in the presence of interstitial flow[J]. Chinese Chemical Letters, ;2019, 30(5): 1038-1042. doi: 10.1016/j.cclet.2019.02.017 shu

Microfluidic three-dimensional biomimetic tumor model for studying breast cancer cell migration and invasion in the presence of interstitial flow

Song Chao ^a,b ,
Gao Dan ^a,b,*, ,
Yuan Tianying ^a,b ,
Chen Yongli ^a,b ,
Liu Liping ^c ,
Chen Xiaowu ^d ,
Jiang Yuyang ^a

a.
State Key Laboratory of Chemical Oncogenomics, The Graduate School at Shenzhen, Tsinghua University, Shenzhen 518055, China
b.
Key Laboratory of Metabolomics at Shenzhen, Shenzhen 518055, China
c.
Department of Hepatobiliary and Pancreatic Surgery, Shenzhen People's Hospital, Second Clinical Medical College of Jinan University, Shenzhen 518000, China
d.
Shenzhen Kivita Innovative Drug Discovery Institute, Shenzhen 518110, China

gao.dan@sz.tsinghua.edu.cn

Received Date: 23 January 2019
Revised Date: 18 February 2019
Accepted Date: 21 February 2019
Available Online: 22 May 2019

Figures(4)

Cell migration and invasion are critical steps in cancer metastasis, which are the major cause of death in cancer patients. Tumor-associated macrophages (TAMs) and interstitial flow (IF) are two important biochemical and biomechanical cues in tumor microenvironment, play essential roles in tumor progression. However, their combined effects on tumor cell migration and invasion as well as molecular mechanism remains largely unknown. In this work, we developed a microfluidic-based 3D breast cancer model by co-culturing tumor aggregates, macrophages, monocytes and endothelial cells within 3D extracellular matrix in the presence of IF to study tumor cell migration and invasion. On the established platform, we can precisely control the parameters related to tumor microenvironment and observe cellular responses and interactions in real-time. When co-culture of U937 with human umbilical vein endothelial cells (HUVECs) or MDA-MB-231 cells and tri-culture of U937 with HUVECs and MDA-MB-231 cells, we found that mesenchymal-like MDA-MB-231 aggregates activated the monocytes to TAM-like phenotype macrophages. MDA-MB-231 cells and IF simultaneously enhanced the macrophages activation by the stimulation of colony-stimulating factor 1 (CSF-1). The activated macrophages and IF further promoted vascular sprouting via vascular endothelial growth factor (VEGFα) signal and tumor cell invasion. This is the first attempt to study the interaction between macrophages and breast cancer cells under IF condition. Taken together, our results provide a new insight to reveal the important physiological and pathological processes of macrophages-tumor communication. Moreover, our established platform with a more mimetic 3D breast cancer model has the potential for drug screening with more accurate results.
- Microfluidics,
- Breast cancer,
- Tumor microenvironment,
- Cell migration and invasion,
- Interstitial flow
1. [1]
  T. Kitamura, B.Z. Qian, J.W. Pollard, Nat. Rev. Immunol. 15(2015) 73-86. doi: 10.1038/nri3789
2. [2]
  L. Yang, Y. Zhang, J. Hematol. Oncol. 10(2017) 58. doi: 10.1186/s13045-017-0430-2
3. [3]
  A. Mantovani, F. Marchesi, A. Malesci, L. Laghi, P. Allavena, Nat. Rev. Clin. Oncol. 14(2017) 399-416. doi: 10.1038/nrclinonc.2016.217
4. [4]
  R. Braster, M. Bogels, R.H. Beelen, M. van Egmond, Immunobiology 222(2017) 21-30. doi: 10.1016/j.imbio.2015.08.011
5. [5]
  M.D. Sorensen, R.H. Dahlrot, H.B. Boldt, S. Hansen, B.W. Kristensen, Neuropathol. Appl. Neurobiol. 44(2018) 185-206. doi: 10.1111/nan.2018.44.issue-2
6. [6]
  K. Sawa-Wejksza, M. Kandefer-Szerszen, Arch. Immunol. Ther. Exp. (Warsz) 66(2018) 97-111. doi: 10.1007/s00005-017-0480-8
7. [7]
  N. Linde, M. Casanova-Acebes, M.S. Sosa, et al., Nat. Commun. 9(2018) 21. doi: 10.1038/s41467-017-02481-5
8. [8]
  M.J. Mitchell, R.K. Jain, R. Langer, Nat. Rev. Cancer 17(2017) 659-675. doi: 10.1038/nrc.2017.83
9. [9]
  M.R. Horsman, P. Vaupel, Front. Oncol. 6(2016) 66.
10. [10]
  M. Rothbauer, H. Zirath, P. Ertl, Lab Chip 18(2018) 249-270. doi: 10.1039/C7LC00815E
11. [11]
  J. Wu, Q. Chen, W. Liu, Z. He, J.M. Lin, TrAC-Trend. Anal. Chem. 87(2017) 19-31. doi: 10.1016/j.trac.2016.11.009
12. [12]
  T. Yuan, D. Gao, S. Li, Y. Jiang, Chin. Chem. Lett. 30(2019) 331-336. doi: 10.1016/j.cclet.2018.07.013
13. [13]
  S. Mao, W. Zhang, Q. Huang, et al., Angew. Chem. Int. Ed. 57(2018) 236-240. doi: 10.1002/anie.201710273
14. [14]
  C. Lin, L. Lin, S. Mao, et al., Anal. Chem. 90(2018) 10326-10333. doi: 10.1021/acs.analchem.8b02133
15. [15]
  M. Jie, H. Lin, Z. He, et al., Sci. China Chem. 61(2018) 236-242. doi: 10.1007/s11426-017-9167-0
16. [16]
  M. Jie, S. Mao, H. Li, J.M. Lin, Chin. Chem. Lett. 28(2017) 1625-1630. doi: 10.1016/j.cclet.2017.05.024
17. [17]
  C.P. Huang, J. Lu, H. Seon, et al., Lab Chip 9(2009) 1740-1748. doi: 10.1039/b818401a
18. [18]
  J. Bai, G. Adriani, T.M. Dang, et al., Oncotarget 6(2015) 25295-25307.
19. [19]
  R. Li, J.D. Hebert, et al., Cancer Res. 77(2017) 279-290. doi: 10.1158/0008-5472.CAN-16-0442
20. [20]
  X. Cui, R.T. Morales, W. Qian, et al., Biomaterials 161(2018) 164-178. doi: 10.1016/j.biomaterials.2018.01.053
21. [21]
  S. Kim, M. Chung, J. Ahn, et al., Lab Chip 16(2016) 4189-4199. doi: 10.1039/C6LC00910G
22. [22]
  E. Um, J.M. Oh, S. Granick, Y.K. Cho, Lab Chip 17(2017) 4171-4185. doi: 10.1039/C7LC00555E
23. [23]
  S. Kim, M. Chung, N.L. Jeon, Biomaterials 78(2016) 115-128. doi: 10.1016/j.biomaterials.2015.11.019
24. [24]
  J.M. Munson, A.C. Shieh, Cancer Manage. Res. 6(2014) 317-328.
25. [25]
  Y. Komohara, Y. Fujiwara, K. Ohnishi, M. Takeya, Adv. Drug Deliv. Rev. 99(2016) 180-185. doi: 10.1016/j.addr.2015.11.009
26. [26]
  Y. Komohara, M. Jinushi, M. Takeya, Cancer Sci. 105(2014) 1-8. doi: 10.1111/cas.12314
27. [27]
  J.W. Song, L.L. Munn, Proc. Natl. Acad. Sci. U. S. A. 108(2011) 15342-15347. doi: 10.1073/pnas.1105316108
28. [28]
  L. Cassetta, J.W. Pollard, Cell Res. 27(2017) 963-964. doi: 10.1038/cr.2017.63
29. [29]
  J.L. Guerriero, A. Sotayo, H.E. Ponichtera, et al., Nature 543(2017) 428-432. doi: 10.1038/nature21409
30. [30]
  A. Satelli, S. Li, Cell. Mol. Life Sci. 68(2011) 3033-3046. doi: 10.1007/s00018-011-0735-1
1. [1]
  Guanghui Lin , Jieyao Chen , Xiaojia Liu , Yitong Lin , Xudong Zhu , Guotao Yuan , Bowen Yang , Shuanshuan Guo , Yue Pan , Jianhua Zhou . Sustained modulation of tumor microenvironment via sorafenib-loaded mesoporous ferromanganese nanozymes for enhanced apoptosis-ferroptosis cancer therapy. Chinese Chemical Letters, 2025, 36(8): 111018-. doi: 10.1016/j.cclet.2025.111018
2. [2]
  Feng Wu , Xuemin Kong , Yixuan Liu , Shuli Wang , Zhong Chen , Xu Hou . Microfluidic-based isolation of circulating tumor cells with high-efficiency and high-purity. Chinese Chemical Letters, 2024, 35(8): 109754-. doi: 10.1016/j.cclet.2024.109754
3. [3]
  Lijuan Liu , Zhihao Zhao , Feiwan Zou , Wukun Liu , Yunlong Lu . Advances in combination therapy for the treatment of estrogen receptor positive breast cancer. Chinese Chemical Letters, 2025, 36(10): 111451-. doi: 10.1016/j.cclet.2025.111451
4. [4]
  Jiangshan Xu , Weifei Zhang , Zhengwen Cai , Yong Li , Long Bai , Shaojingya Gao , Qiang Sun , Yunfeng Lin . Tetrahedron DNA nanostructure/iron-based nanomaterials for combined tumor therapy. Chinese Chemical Letters, 2024, 35(11): 109620-. doi: 10.1016/j.cclet.2024.109620
5. [5]
  Keqiang Shi , Xiujuan Hong , Dongyan Xu , Tao Pan , Huiwen Wang , Hongru Feng , Cheng Guo , Yuanjiang Pan . Analysis of RNA modifications in peripheral white blood cells from breast cancer patients by mass spectrometry. Chinese Chemical Letters, 2025, 36(3): 110079-. doi: 10.1016/j.cclet.2024.110079
6. [6]
  Xinyue Han , Yunhan Yang , Jiayin Lu , Yuxiang Lin , Dongxue Zhang , Ling Lin , Liang Qiao . Efficient serum lipids profiling by TiO₂-dopamin-assisted MALDI-TOF MS for breast cancer detection. Chinese Chemical Letters, 2025, 36(5): 110183-. doi: 10.1016/j.cclet.2024.110183
7. [7]
  Lulu He , Le Wang , Zhen He , Yiqian Yang , Cheng Heng Pang , Aiguo Wu , Bencan Tang , Juan Li . An imine-linked covalent organic framework with intrinsic photo-induced mitochondrial regulation for breast cancer therapy. Chinese Chemical Letters, 2025, 36(9): 110717-. doi: 10.1016/j.cclet.2024.110717
8. [8]
  Jia Wang , Yunxiu Fan , Shilin Xu , Zhouxue Wu , Tian Hu , Yun Lu , Yue Li , Kang Xiong , Hongjun Deng , Jingrong Huang , Bo Yang , Shaozhi Fu . Self-propelled biomotors co-deliver doxorubicin liposomes and aPD-1 antibody to fight breast cancer. Chinese Chemical Letters, 2026, 37(2): 111607-. doi: 10.1016/j.cclet.2025.111607
9. [9]
  Huijie An , Chen Yang , Zhihui Jiang , Junjie Yuan , Zhongming Qiu , Longhao Chen , Xin Chen , Mutu Huang , Linlang Huang , Hongju Lin , Biao Cheng , Hongjiang Liu , Zhiqiang Yu . Luminescence-activated Pt(Ⅳ) prodrug for in situ triggerable cancer therapy. Chinese Chemical Letters, 2024, 35(7): 109134-. doi: 10.1016/j.cclet.2023.109134
10. [10]
  Fengyun Li , Zerong Pei , Shuting Chen , Gen li , Mengyang Liu , Liqin Ding , Jingbo Liu , Feng Qiu . Multifunctional nano-herb based on tumor microenvironment for enhanced tumor therapy of gambogic acid. Chinese Chemical Letters, 2024, 35(5): 108752-. doi: 10.1016/j.cclet.2023.108752
11. [11]
  Boyuan Liu , Zixu Liu , Ping Wang , Yu Zhang , Haibing He , Tian Yin , Jingxin Gou , Xing Tang . Nanomedicine-based targeting delivery systems for peritoneal cavity localized therapy: A promising treatment of ovarian cancer and its peritoneal metastasis. Chinese Chemical Letters, 2025, 36(6): 110229-. doi: 10.1016/j.cclet.2024.110229
12. [12]
  Jiaojiao Yang , Shaokun Yang , Wei Cheng , Jie Wu , Haijing Qu , Han Chen , Zhiran Duan , Yuqing Pan , Ning Wang , Chao Wang , Jian Gao , Bai Xiang , Xiangdong Xue . Self-assembled cyclodextrin-porphyrin nanoplatform for synergistic chemo-phototherapy and targeted delivery of camptothecin against breast cancer. Chinese Chemical Letters, 2026, 37(4): 111901-. doi: 10.1016/j.cclet.2025.111901
13. [13]
  Zhiqiang Cui , Dongxiang Zhang , Yanru Huang , Chunyu Shao , Yiming Zhang , Changliang Sun , Xin-Dong Jiang , Xiaohong Sun , Qinghuan Xiao . Novel 1-phenylethyl-containing aza-BDOIPY for phototherapy and simultaneous monitoring of tumor immune microenvironment reprogramming. Chinese Chemical Letters, 2025, 36(7): 110460-. doi: 10.1016/j.cclet.2024.110460
14. [14]
  Kaiyue Yang , Yifan Zhang , Shamei Luo , Chenxi Yu , Lin Chen , Qingyu Yu , Chenlu Huang , Guilei Ma , Linhua Zhang , Dunwan Zhu . Multifunctional nanoadjuvants-aided synergistic photothermal-immunotherapy of tumor. Chinese Chemical Letters, 2026, 37(4): 112324-. doi: 10.1016/j.cclet.2025.112324
15. [15]
  Li Fu , Ziye Su , Shuyang Wu , Yanfen Cheng , Chuan Hu , Jinming Zhang . Redox-responsive hyaluronic acid-celastrol prodrug micelles with glycyrrhetinic acid co-delivery for tumor combination therapy. Chinese Chemical Letters, 2025, 36(5): 110227-. doi: 10.1016/j.cclet.2024.110227
16. [16]
  Shiyu Hou , Maolin Sun , Liming Cao , Chaoming Liang , Jiaxin Yang , Xinggui Zhou , Jinxing Ye , Ruihua Cheng . Computational fluid dynamics simulation and experimental study on mixing performance of a three-dimensional circular cyclone-type microreactor. Chinese Chemical Letters, 2024, 35(4): 108761-. doi: 10.1016/j.cclet.2023.108761
17. [17]
  Jun Lu , Jinrui Yan , Yaohao Guo , Junjie Qiu , Shuangliang Zhao , Bo Bao . Controlling solid form and crystal habit of triphenylmethanol by antisolvent crystallization in a microfluidic device. Chinese Chemical Letters, 2024, 35(4): 108876-. doi: 10.1016/j.cclet.2023.108876
18. [18]
  Cheng Wang , Ji Wang , Dong Liu , Zhi-Ling Zhang . Advances in virus-host interaction research based on microfluidic platforms. Chinese Chemical Letters, 2024, 35(12): 110302-. doi: 10.1016/j.cclet.2024.110302
19. [19]
  Guifeng Wen , Zheyuan Zhong , Yue Fan , Xuelin Tian , Shilin Huang . Multidimensional droplet manipulation on superhydrophobic surfaces using acoustic tweezers. Chinese Chemical Letters, 2025, 36(5): 110672-. doi: 10.1016/j.cclet.2024.110672
20. [20]
  Zhendong Liu , Sainan Liu , Bin Liu , Qi Meng , Meng Yuan , Chunzheng Yang , Yulong Bian , Ping'an Ma , Jun Lin . Fe(Ⅲ)-juglone nanoscale coordination polymers for cascade chemodynamic therapy through synergistic ferroptosis and apoptosis strategy. Chinese Chemical Letters, 2024, 35(11): 109626-. doi: 10.1016/j.cclet.2024.109626

Get Citation

PDF

XML

Metrics

PDF Downloads(5)
Abstract views(1813)
HTML views(31)

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142